Originally, ConjuChem Biotechnologies, the developer of DAC, referred to the molecule containing DAC as simply CJC-1295
This product is not intended to diagnose, treat, cure, or prevent any disease." This is the standard regulatory framing for all dietary supplements in the United States, and buyers should understand that FDA "not evaluated" status applies to virtually every supplement on the market - it reflects the regulatory category, not a specific quality or efficacy finding about this product
However, other research suggests L-carnitine provides no benefits
A faint yellow tint in reconstituted Lipo C is normal and results from the natural colour of L-carnitine and B-vitamin cofactors in the formulation this does not indicate contamination or degradation
What are the side effects of cagrisema
GM-CSF, granulocyte-macrophage colony stimulating factor